Patents Assigned to Merck Patents GmbH
  • Patent number: 9520565
    Abstract: The invention relates to novel organic semiconducting compounds containing one or more dialkylidene-s-indacenodiheteroarene groups, methods for their preparation and educts or intermediates used therein, polymers, blends, mixtures and formulations containing them, the use of the compounds, polymers, blends, mixtures and formulations as semiconductor in organic electronic (OE) devices, especially in organic photovoltaic (OPV) devices, and to OE and OPV devices comprising these compounds, polymers, blends, mixtures or formulations.
    Type: Grant
    Filed: May 30, 2012
    Date of Patent: December 13, 2016
    Assignee: MERCK PATENT GMBH
    Inventors: Changsheng Wang, Nicolas Blouin, Mansoor D'Lavari, Steven Tierney, Lana Nanson
  • Patent number: 9517227
    Abstract: Novel dihydropyrazole derivatives of formula (I) wherein L, R, R3, R4, R5, R6, R7, X1, X2, X3, X4, Y, m and n have the meaning according to the claims, are positive allosteric modulators of the FSH receptor, and can be employed, inter alia, for the treatment of fertility disorders.
    Type: Grant
    Filed: June 10, 2014
    Date of Patent: December 13, 2016
    Assignee: Merck Patent GmbH
    Inventors: Henry Yu, Thomas E. Richardson, Robert James Foglesong, Lizbeth Celeste Deselm, Andreas Goutopoulos
  • Patent number: 9517977
    Abstract: The present invention relates to compounds of the formula (I), to mixtures of the said compounds with emitter compounds, to the use of compounds of the formula (I) and the said mixtures in electronic devices, and to electronic devices containing one or more compounds of the formula (I) and/or mixtures of compounds of the formula (I) with emitter compounds.
    Type: Grant
    Filed: October 1, 2010
    Date of Patent: December 13, 2016
    Assignee: Merck Patent GmbH
    Inventors: Hubert Spreitzer, Jochen Schwaiger, Heinrich Becker
  • Publication number: 20160359060
    Abstract: This invention relates to a precursor material, which can be decomposed to form semiconductors and metal oxides, or more generally, materials for electronic components. The precursors comprise metal complexes of hydroxamato ligands. The invention further relates to a preparation process for thin inorganic films comprising various metals (e.g. Cu/In/Zn/Ga/Sn) and oxygen, selenium and/or sulfur. The thin films can be used in photovoltaic panels (solar cells), other semiconductor or electronic devices, and other applications using such films. The process uses molecular, metal containing precursor complexes with hydroxamato ligands. These can be combined in the process with chalcogenide sources or oxygen. Exemplarily, various metal oxides and copper-based chalcopyrites of the I-III-VI2 type are prepared with high purity at low temperatures.
    Type: Application
    Filed: January 14, 2015
    Publication date: December 8, 2016
    Applicant: Merck Patent GmbH
    Inventors: Ranjan Deepak DESHMUKH, Rebekah HOOKER, Pawel MISKIEWICZ, Joerg SCHNEIDER, Mathias NOWOTNY
  • Patent number: 9512102
    Abstract: 4,6-difluorodibenzothiophene compounds of formula I the preparation thereof, the use thereof as components in liquid-crystalline media and electro-optical display elements which contain the liquid-crystalline media.
    Type: Grant
    Filed: April 22, 2015
    Date of Patent: December 6, 2016
    Assignee: MERCK PATENT GMBH
    Inventors: Volker Reiffenrath, Harald Hirschmann
  • Patent number: 9515274
    Abstract: This disclosure features an article that includes first and second electrodes, a photoactive layer between the first and second electrodes, and a hole carrier layer between the first electrode and the photoactive layer. The hole carrier layer includes a Cu(I)-containing material. The article is configured as a photovoltaic cell.
    Type: Grant
    Filed: July 30, 2013
    Date of Patent: December 6, 2016
    Assignee: MERCK PATENT GMBH
    Inventors: Kethinni G. Chittibabu, Nirupama Kattamuri, Franz Rene Kogler, David P. Waller, Allesandro Zedda
  • Patent number: 9515266
    Abstract: Triphenylene derivatives, in particular for use as triplet matrix materials in organic electroluminescent devices, one of example of which is represented by formula I. The invention furthermore relates to a process for the preparation of the triphenylene derivatives and to electronic devices comprising the triphenylene derivatives.
    Type: Grant
    Filed: September 24, 2012
    Date of Patent: December 6, 2016
    Assignee: Merck Patent GmbH
    Inventors: Anja Jatsch, Rémi Manouk Anémian, Bernd Schroeder, Arne Buesing, Philipp Stoessel, Christof Pflumm, Jonas Valentin Kroeber, Thomas Eberle
  • Patent number: 9507185
    Abstract: The invention relates to a temperature-controlled switching element for the regulation of light transmission. The invention furthermore relates to a mixture comprising at least one liquid-crystalline compound, at least one monomer compound which represents a monofunctional compound, and at least one monomer compound which represents a multifunctional compound. The invention again furthermore relates to the use of the said mixture for the production of the switching element according to the invention.
    Type: Grant
    Filed: September 25, 2012
    Date of Patent: November 29, 2016
    Assignee: Merck Patent GmbH
    Inventors: Michael Junge, Andreas Beyer
  • Patent number: 9505848
    Abstract: The present invention provides an engineered multidomain protein including at least two nonidentical engineered domains, each of which contains a protein-protein interaction interface containing amino acid sequence segments derived from two or more existing homologous parent domains, thereby conferring on the engineered domains assembly specificities distinct from assembly specificities of the parent domains. In particular, the engineered domains form heterodimers with one another preferentially over forming homodimers. Methods of designing and using the engineered proteins are also included.
    Type: Grant
    Filed: October 3, 2014
    Date of Patent: November 29, 2016
    Assignee: Merck Patent GmbH
    Inventors: Jonathan H. Davis, James S. Huston
  • Patent number: 9499459
    Abstract: The present invention relates to substituted benz[a]anthracene derivatives, to the preparation and use thereof in organic electroluminescent devices, and to organic electroluminescent devices, in particular blue-emitting devices, in which these compounds are used as matrix material or dopant in the emitting layer and/or as hole-transport material and/or as electron-transport material.
    Type: Grant
    Filed: July 5, 2010
    Date of Patent: November 22, 2016
    Assignee: Merck Patent GmbH
    Inventors: Amir Hossain Parham, Arne Buesing, Holger Heil, Philipp Stoessel, Michael Holbach
  • Patent number: 9502658
    Abstract: The invention relates to improved fullerene derivatives, to methods for their synthesis and any educts or intermediates used in such methods, to compositions and formulations containing fullerene derivatives, to the use of the fullerene derivatives, compositions and formulations in, or for the preparation of, organic electronic (OE) devices like for example organic photovoltaic (OPV) devices or organic photodetectors (OPD), and to OE, OPV and OPD devices comprising, or being prepared from, these fullerene derivatives, compositions or formulations.
    Type: Grant
    Filed: April 21, 2014
    Date of Patent: November 22, 2016
    Assignees: NANO-C, INC., MERCK PATENT GMBH
    Inventors: Edward A. Jackson, Henning Richter, Nicolas Blouin, Stéphane Berny
  • Patent number: 9499474
    Abstract: The invention relates to a process for producing compounds containing at least one arylamino group by means of a coupling reaction of an amino compound with an aryl compound, using a strong base.
    Type: Grant
    Filed: October 19, 2012
    Date of Patent: November 22, 2016
    Assignee: Merck Patent GmbH
    Inventors: Oliver Kaufhold, Hubert Spreitzer, Stefan Riedmueller
  • Patent number: 9498475
    Abstract: Novel benzamide derivatives of formula (I) wherein W1, W2, R1 to R7, R6, X and Y have the meaning according to the claims, are positive allosteric modulators of the FSH receptor, and can be employed, inter alia, for the treatment of fertility disorders.
    Type: Grant
    Filed: September 24, 2015
    Date of Patent: November 22, 2016
    Assignee: Merck Patent GmbH
    Inventors: Henry Yu, Andreas Goutopoulos, Thomas E. Richardson, Jiezhen Li, Brian H. Heasley, Pandi Bharathi
  • Patent number: 9499508
    Abstract: The present invention relates to the use of compounds of the formula (I) for the care, preservation or improvement of the general condition or appearance of the skin or hair, and to preparations comprising compounds of the formula (I).
    Type: Grant
    Filed: November 14, 2011
    Date of Patent: November 22, 2016
    Assignee: MERCK PATENT GMBH
    Inventors: Christophe Carola, Tatjana Mueller
  • Publication number: 20160333270
    Abstract: The compounds of the formula I, and a liquid-crystalline medium, preferably having a nematic phase and negative dielectric anisotropy, which comprises a) one or more compounds of the formula I and b) one or more compounds of the formulae II-1 to II-4, in which the parameters have the meanings defined herein, are suitable for use in an electro-optical display, particularly in an active-matrix display based on the VA, ECB, PALC, FFS or IPS effect.
    Type: Application
    Filed: May 12, 2016
    Publication date: November 17, 2016
    Applicant: Merck Patent GmbH
    Inventors: Martin ENGEL, Thorsten KODEK, Ingo ALMEROTH, Rocco FORTTE
  • Publication number: 20160333184
    Abstract: The present invention relates to pigments based on bismuth compounds and to the use thereof, preferably as laser-absorbent additive, and to a process for the preparation thereof.
    Type: Application
    Filed: December 17, 2014
    Publication date: November 17, 2016
    Applicant: Merck Patent GmbH
    Inventors: Helge Bettina KNIESS, Franciscus Gerardus Henricus VAN DUIJNHOVEN, Franciscus Wilhelmus Maria GELISSEN
  • Publication number: 20160331748
    Abstract: 3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile or a pharmaceutically acceptable salt and/or solvate thereof for the use for the treatment of renal cell carcinoma (RCC).
    Type: Application
    Filed: December 16, 2014
    Publication date: November 17, 2016
    Applicant: Merck Patent GmbH
    Inventors: Friedhelm BLADT, Manja FRIESE-HAMIM
  • Patent number: 9494808
    Abstract: This invention relates to particles comprising a pigment core particle encapsulated by a polymer, a process for their preparation, electrophoretic fluids comprising such particles, and electrophoretic display devices comprising such fluids.
    Type: Grant
    Filed: May 7, 2013
    Date of Patent: November 15, 2016
    Assignee: Merck Patent GmbH
    Inventors: Louise Diane Farrand, Emily Jane Thomas, Claire Topping, Jonathan Henry Wilson
  • Patent number: 9492681
    Abstract: The present invention relates to a cells and cell tissue treatment device and use thereof.
    Type: Grant
    Filed: January 16, 2012
    Date of Patent: November 15, 2016
    Assignee: Merck Patent GmbH
    Inventors: Ewald Aydt, Herwig Buchholz, Junyou Pan
  • Patent number: 9493736
    Abstract: The present invention relates to a method for the lysis of cells, especially bacterial cells and the isolation of nucleic acids. The sample is treated with lysis solution that comprises at least one liquid that is not miscible with water and heated. Afterwards the mixture is cooled down and water is added so that after cooling a two phase system is generated. The nucleic acids can be found in the aqueous phase.
    Type: Grant
    Filed: March 28, 2012
    Date of Patent: November 15, 2016
    Assignee: MERCK PATENT GMBH
    Inventors: Joerg Slaghuis, Peter Rossmanith, Sabine Fuchs, Patrick Julian Mester, Martin Wagner